nm23-H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix

Pathology International

Volumn 48, Issue 10, 1998, Pages 806-811

  Lee, C Soon ^a,b   Gad, Jacqueline ^c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Cervical neoplasia; Immunohistochemistry; Nm23H1; Tumor suppressor gene

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE A; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERUS PROLAPSE; VIRUS INFECTION; WART VIRUS;

EID: 14444268279     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03841.x     Document Type: Article

References (27)

1. Steeg PS, Bevilacqua G, Kopper L et al. Evidence for a novel gene associated with low tumour metastatic potential. J. Natl Cancer Inst. 1988; 80: 200-204.
2. Leone A, McBride OW, Weston A et al. Somatic allelic deletion of nm23 in human cancer. Cancer Res. 1991; 51: 2490-2493.
3. Bevilacqua G, Sobel ME, Liotta LA, Steeg PS. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res. 1989; 49: 5185-5190.
4. Hennessy C, Henry JA, May FEB, Westly BR, Angus B, Lennard TWJ. Expression of the anti-metastatic gene nm23 in human breast cancer; association with good prognosis. J. Natl Cancer Inst. 1991; 83: 281-285.
5. Lee CS, Pirdas-Zivcic A. nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Pathology 1994; 26: 448-452.
6. Conn KH, Wang F, Desoto-La Paix F et al. Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. Lancet 1991; 338: 722-724.
7. Barnes R, Masood S, Barker E et al. Low nm23 protein expression in infiltrating ductal breast carcinomas correlates with reduced patient survival. Am. J. Pathol. 1991; 139: 245-250.
8. Florenes VA, Aamdal S, Myklebost O et al. Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression. Cancer Res. 1992; 52: 6088-6091.
9. Lee CS, Redshaw A, Boag G. Nm23-H1 protein immunoreactivity in laryngeal cancers. Cancer 1996; 77: 2246-2250.
10. Herrington CS. Human papillomaviruses and cervical neoplasia. II: Interaction of HPV with other factors. J. Clin. Pathol. 1995; 48: 1-6.
11. Leone A, Flatow U, King CR et al. Reduced tumor incidence, metastatic potential and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991; 65: 25-35.
12. Matrisian LM, Bowden GT, Krieg P et al. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumours. Proc. Natl Acad. Sci. USA 1986; 83: 9413-9417.
13. McGregor JM, Yu CCW, Dublin EA, Barnes DM, Levison DA, MacDonald DM. p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Br. J. Dermatol. 1993; 128: 606-611.
14. Stahl JA, Leone A, Rosengard AM et al. Identification of a second human nm23 gene, nm23-H2. Cancer Res. 1991; 51: 445-449.
15. Varesco L, Caligon MA, Simi P et al. The nm23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with Bgl II. Genes Chromosomes Cancer 1992; 4: 84-88.
16. Wang L, Patel U, Ghosh L, Chen H-C, Banerjee S. Mutation in the nm23 gene is associated with metastasis in colorectal cancer. Cancer Res. 1993; 53: 717-720.
17. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T, Shiku H. Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int. J. Cancer 1993; 55: 66-71.
18. Toulas C, Marek E, Cheutin F, Soula G, Favre G. Expression of Nm23-H1 protein is related to metastasis free survival, tumor size and oestrogen receptor level in human breast cancer. Proc. Am. Assoc. Cancer Res. 1994; 35: 224.
19. Vecchione A, Cermele C, Giovagnoli MR et al. p53 Expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. Gynecol. Oncol. 1994; 55: 343-348.
20. Marone M, Scambia G, Ferrandina G et al. nm23 Expression in endometrial and cervical cancer: Inverse correlation with lymph node involvement and myometrial invasion. Br. J. Cancer 1996; 74: 1063-1068.
21. Boix L, Bruix J, Campo E et al. nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterol. 1994; 107: 486-491.
22. Martinez JA, Prevot S, Nordlinger B et al. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages. Gut 1995; 37: 712-720.
23. Hailat N, Keim DR, Melhem RF et al. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J. Clin. Invest. 1991; 88: 341-345.
24. Simpson JF, O'Malley F, Dupont WD, Page DL. Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma. Cancer 1994; 73: 2351-2358.
25. Haut M, Steeg PS, Willson JKV, Markowitz SD. Induction of nm23 gene expression in human colonie neoplasms and equal expression in colon tumors of high and low metastatic potential. J. Natl Cancer Inst. 1991; 83: 712-716.
26. Hori K, Uematsu K, Yasoshima H, Sakurai K, Yamada A, Ohya M. Immunohistochemical analysis of the nm23 gene products in testicular seminoma. Pathol. Int. 1997; 47: 288-292.
27. Sawan A, Lascu I, Veron M et al. NDP-K/nm23 expression in human breast cancer in relation to relapse, survival, and other prognostic factors: An immunohistochemical study. J. Pathol. 1994; 172: 27-34.